LUPIN INVESTMENT CO. LTD.

LUPIN INVESTMENT CO. LTD. is a Series C+ fund in the US, India, Europe, Canada, Australia, Latin America, South Africa and Philippines investing in Healthcare and pharmaceuticals.

Stages: Series C+
Sectors: Healthcare, pharmaceuticals
Invests in: US-wide, India, Europe, Canada, Australia, Latin America, South Africa, Philippines
Founded: 1968
Website: lupin.com

Check size not disclosed

Thesis

Lupin Investment Co. Ltd. is an investment advisory firm, registered as an Exempt Reporting Adviser (ERA) with the SEC. While specific AUM for Lupin Investment Co. Ltd. is not publicly disclosed, it is closely associated with Lupin Limited, a multinational pharmaceutical company founded in 1968. Lupin Limited's strategy focuses on innovation and expansion in the pharmaceutical sector, particularly in complex generics, specialty medicines, and differentiated products. The company has a significant global presence, including developed markets like the US, Europe, and Canada, and emerging markets in Latin America and Africa. Lupin Limited reported total revenue of approximately USD 2.7 billion and total assets of approximately USD 3.0 billion for FY25. Lupin Investment Co. Ltd. may be involved in managing private funds such as 'LUPIN CAPITAL FUND I, L.P.'. The firm's primary business appears to be investment advisory services, with a strong connection to the pharmaceutical industry through its parent entity.

Common questions

Does LUPIN INVESTMENT CO. LTD. invest at the Series C+ stage?

Yes. LUPIN INVESTMENT CO. LTD. lists Series C+ among the stages it invests in.

Where does LUPIN INVESTMENT CO. LTD. invest?

LUPIN INVESTMENT CO. LTD. invests in the US, India, Europe, Canada, Australia, Latin America, South Africa and Philippines.